Should You Buy Petros Pharmaceuticals Inc (PTPI) Stock?
$Petros Pharmaceuticals Inc(PTPI)$ is down Monday morning, with the stock declining -30.28% in pre-market trading to 3.2. PTPI's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 131 out of 146 industries, Petros Pharmaceuticals Inc ranks higher than 100% of stocks. Petros Pharmaceuticals Inc has risen 196.13% over the past month, closing at $1.53 on March 20. During this period of time, the stock fell as low as $0.96 and as high as $8.52.
Petros Pharmaceuticals Inc has a Long-Term Technical rank of 77by investorsobserver. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 23% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 129 by this metric, PTPI ranks better than 129% of stocks.
Important Dates for Investors in PTPI:
-Petros Pharmaceuticals Inc is set to release earnings on 5/15/2023. Over the last 12 months, the company has reported EPS of $-9.78.
source：investorsobserver
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
